SCHEMBL991632

SCHEMBL991632

COc1ccc(COc2ccc(C(=O)O)nc2-c2cc(F)c(Cl)c(OC)c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 3/20 0.43
PTGER1 P34995 2/20 0.42
CTSA P10619 4/20 0.41
NPC1 O15118 1/20 0.40
POLB P06746 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
FFAR1 O14842 3/20 0.40
PPARD Q03181 2/20 0.39
FFAR4 Q5NUL3 1/20 0.39
XDH P47989 2/20 0.39
ERN1 O75460 1/20 0.39
KEAP1 Q14145 1/20 0.39
NFE2L2 Q16236 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL951351 0.80 KDM4E (0.43) CTSARAB9A
SCHEMBL2492927 0.77 KMO (0.44) MRGPRX4NPC1POLBRAB9ASMN1; SMN2
SCHEMBL2489148 0.76 PPARD (0.43) MRGPRX4PTGER1CTSANPC1POLB
SCHEMBL2490382 0.74 KDM4E (0.43) MRGPRX4PTGER1CTSAPPARD
SCHEMBL934656 0.73 CTSA (0.44) CTSA
SCHEMBL2491639 0.73 MCL1 (0.43) MRGPRX4PTGER1
SCHEMBL999406 0.73 NPC1 (0.52) PTGER1NPC1POLBRAB9ASMN1; SMN2
SCHEMBL4038711 0.71 FFAR1 (0.42) MRGPRX4NPC1POLBRAB9ASMN1; SMN2
SCHEMBL2492027 0.71 CSNK2A2 (0.41) MRGPRX4NPC1POLBRAB9ASMN1; SMN2
SCHEMBL2488886 0.70 CSNK2A2 (0.39) MRGPRX4CTSANPC1POLBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011007091-A1 DERIVATIVES OF 5,6-BISARYL-2-PYRIDINE-CARBOXAMIDE, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF AS UROTENSIN-II RECEPTOR ANTAGONISTS SANOFI-AVENTIS (FR) 2011-01-20 WO disclosed